|
||
|
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
Forward Ventures announced 24 million Series A financing of Tioga Pharmaceuticals Incorporated
January 12th, 2006 No comments
Forward Ventures announced last week that it has led the $24 million Series A financing of Tioga Pharmaceuticals Incorporated.
Tioga Pharmaceuticals is engaged in the development of novel therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline, a proprietary small molecule, for the treatment of irritable bowel syndrome (IBS) and post operative ileuses. Forward Ventures founded Tioga and was joined in the Series A by New Leaf Venture Partners and BB Biotech Ventures II. The capital will be used to fund a 600 patient phase IIb clinical trial for irritable bowel syndrome and a 130 patient phase IIa trial for post operative ileuses.
Dr. Allen Mangel, Tioga’s Chief Medical Officer and the former worldwide head of gastrointestinal clinical development at GlaxoSmithKline, stated: “I am excited to be leading the clinical development of asimadoline. I believe this is the most promising medicine in development today for the treatment of IBS.”
Asimadoline is a proprietary small molecule therapeutic discovered and developed by Merck KGaA of Darmstadt, Germany. Tioga has acquired all rights to asimadoline from Merck. The compound has been tested in nearly 800 subjects and demonstrated a promising safety profile. It has shown encouraging clinical efficacy for the treatment of irritable bowel syndrome and has the potential for treating other gastrointestinal diseases.
About Forward Ventures
Forward Ventures is Southern California’s largest venture fund focused exclusively on life sciences. Forward invests in early, mid and late stage biopharmaceutical and device companies.
Leave a reply
Latest Headlines:
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility